| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0006 |